Literature DB >> 15253599

Back pain-clinical assessment.

Steve Jensen1.   

Abstract

BACKGROUND: Low back pain accounts for approximately 5% of all general practice consultations. Although the majority of patients will have somatic low back pain of musculoskeletal origin, vigilance in excluding 'red flag' conditions is paramount. The identification of 'yellow flags', ie. psychosocial stress factors, becomes important in patients not making a rapid recovery, and these factors need to be identified and rectified early, lest they lead to chronic pain and disability.
OBJECTIVE: This article presents a simple examination of the lower back designed with general practice in mind. It is based on the 'look, move, feel' paradigm of clinical orthopaedic examination. DISCUSSION: A thorough and conscientious physical examination is not time consuming. It reassures the patient that the practitioner is interested and concerned about their problem. In acute low back pain, this is the springboard to a simple effective management program and improved outcomes. It also confirms the site of pain, and is important in monitoring disability. However, there are no clinical signs, either singly or in multiples, which allow a valid anatomico-pathological diagnosis to be made.

Entities:  

Mesh:

Year:  2004        PMID: 15253599

Source DB:  PubMed          Journal:  Aust Fam Physician        ISSN: 0300-8495


  2 in total

1.  Ondansetron Does Not Reduce Withdrawal in Patients With Physical Dependence on Chronic Opioid Therapy.

Authors:  Larry F Chu; John Sun; Anna Clemenson; Matthew J Erlendson; Tom Rico; Erika Cornell; Hannah Obasi; Zahra N Sayyid; Ellen M Encisco; Jeff Yu; Jamison G Gamble; Ian Carroll; J David Clark
Journal:  J Addict Med       Date:  2017 Sep/Oct       Impact factor: 3.702

2.  Aceclofenac-tizanidine in the treatment of acute low back pain: a double-blind, double-dummy, randomized, multicentric, comparative study against aceclofenac alone.

Authors:  Anil Pareek; Nitin Chandurkar; A S Chandanwale; Ratnakar Ambade; Anil Gupta; Girish Bartakke
Journal:  Eur Spine J       Date:  2009-05-07       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.